about
BAK overexpression mediates p53-independent apoptosis inducing effects on human gastric cancer cellsPonicidin inhibits monocytic leukemia cell growth by induction of apoptosis.Synergistic effect of magnetic nanoparticles of Fe(3)O(4) with gambogic acid on apoptosis of K562 leukemia cellsA Potential of microRNAs for High-Content ScreeningGuggulsterone inhibits human cholangiocarcinoma Sk-ChA-1 and Mz-ChA-1 cell growth by inducing caspase-dependent apoptosis and downregulation of survivin and Bcl-2 expression.Sensitization of TRAIL-resistant LNCaP cells by resveratrol (3, 4', 5 tri-hydroxystilbene): molecular mechanisms and therapeutic potential.Curcumin enhances the apoptosis-inducing potential of TRAIL in prostate cancer cells: molecular mechanisms of apoptosis, migration and angiogenesis.Identification of a novel Bcl-2 promoter region that counteracts in a p53-dependent manner the inhibitory P2 region.The contribution of c-Jun N-terminal kinase activation and subsequent Bcl-2 phosphorylation to apoptosis induction in human B-cells is dependent on the mode of action of specific stressesBcl-2 family proteins as regulators of oxidative stress.Ziyuglycoside II-induced apoptosis in human gastric carcinoma BGC-823 cells by regulating Bax/Bcl-2 expression and activating caspase-3 pathway.Small mitochondria-targeting molecules as anti-cancer agents.CELLFOOD™ induces apoptosis in human mesothelioma and colorectal cancer cells by modulating p53, c-myc and pAkt signaling pathways.A transcriptional regulatory element in the coding sequence of the human Bcl-2 gene.Ponicidin induces apoptosis via JAK2 and STAT3 signaling pathways in gastric carcinoma.Quercetin promotes degradation of survivin and thereby enhances death-receptor-mediated apoptosis in glioma cells.Therapy Effects of Wogonin on Ovarian Cancer Cells.PYGB siRNA inhibits the cell proliferation of human osteosarcoma cell lines.
P2860
Q21261236-D2575D06-085E-4F9B-A2C9-261A9F819611Q33423866-FD182C90-4E2E-4906-AB44-98C7AFE8E10DQ33518496-56B469B5-2BE9-433D-930E-C3E0A676ED2BQ35212807-08F37EAA-C40F-4D5C-BE07-BE4E9539433CQ35856684-52BD47CF-EADF-414E-8193-E3D2ADEE37A0Q36059686-92B71085-127C-4345-AAA0-BBB1E803D6A1Q36151210-6FFA4D22-0DB8-43DE-9977-B31DFB35D1A1Q36529009-A1A05F86-44A8-404D-B7E3-00D06DDD182DQ36595596-FC7DA63F-FD22-43E5-9A75-2AFF9FD34A00Q37367025-60B72515-C7AF-410D-97C9-AF0319BA471CQ37371534-D8105DE2-0BAD-4094-B6E8-9149401B425EQ37648872-4651F9FC-5E2D-4EE7-A794-3E95C0B4F57EQ37684694-DCC16F0F-9B8C-47A7-ACDF-E09DC8CE6B71Q38332936-FA5213A3-130F-4055-8441-4CD81E841698Q38920058-E53F4D75-522A-4FB2-B9FD-4A1A99CF4085Q39923672-DA8B97BB-D536-4C95-8DD7-F5545846C470Q47095255-94FF8214-797F-4DDF-A4FB-3FDA6F25764BQ54977748-43873849-F881-45BA-8A8C-616BA37432C7
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Targeting BCL-2-related proteins in cancer therapy.
@ast
Targeting BCL-2-related proteins in cancer therapy.
@en
type
label
Targeting BCL-2-related proteins in cancer therapy.
@ast
Targeting BCL-2-related proteins in cancer therapy.
@en
prefLabel
Targeting BCL-2-related proteins in cancer therapy.
@ast
Targeting BCL-2-related proteins in cancer therapy.
@en
P1476
Targeting BCL-2-related proteins in cancer therapy
@en
P2093
David M Hockenbery
Michael K Manion
P304
P433
P577
2003-07-01T00:00:00Z